Offerpad Solutions Inc. 8-K

What Happened
Offerpad Solutions Inc. announced it received a notice from the New York Stock Exchange on March 3, 2026 stating it is not in compliance with Section 802.01C of the NYSE Listed Company Manual because the average closing price of its Class A common stock was below $1.00 over a consecutive 30 trading‑day period. The notice does not cause immediate delisting. On March 5, 2026 Offerpad informed the NYSE it intends to cure the deficiency, and on March 6, 2026 the company issued a press release disclosing the notice (filed as Exhibit 99.1 to the 8‑K).

Key Details

• NYSE notice dated March 3, 2026 for non‑compliance with the $1.00 minimum average closing price (Section 802.01C).
• Company has a six‑month cure period from receipt of the notice to regain compliance.
• To regain compliance during the cure period, Offerpad must have on the last trading day of any calendar month both (1) a closing price of at least $1.00 and (2) a 30‑trading‑day average closing price of at least $1.00.
• Offerpad may consider options such as a reverse stock split (which would require shareholder approval no later than its next annual meeting); if a shareholder‑approved corrective action is undertaken and the price promptly exceeds $1.00 and stays above that level for 30 trading days, the condition is deemed cured.

Why It Matters
For investors, the notice signals the company’s stock price has fallen below NYSE standards, which can increase regulatory risk and potential volatility. The shares will continue trading on the NYSE while Offerpad seeks to cure the deficiency, but failure to return to compliance within the cure period could lead to delisting under NYSE rules. Management’s mention of a possible reverse stock split means shareholders should watch for corporate actions and the company’s next annual meeting, as such actions can affect share count and per‑share value.